SOLIGENIX, INC. Convertible Debt, Noncurrent
SOLIGENIX, INC. (SNGX) had Convertible Debt, Noncurrent of $10.00 million as of 2021-03-31, per its 10-Q filed 2021-05-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2021-05-18
- 2021-03-31: Convertible Debt, Noncurrent $10.00M.
- 2020-12-31: Convertible Debt, Noncurrent $10.00M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2021-03-31 | $10.00M 10-Q · filed 2021-05-18 |
| 2020-12-31 | $10.00M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |